Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
OSI Pharmaceuticals is committed to “shaping medicine and changing lives” by discovering, developing and commercializing high-quality and novel pharmaceutical products that extend life or improve the quality of life for patients with cancer, eye diseases and diabetes. The driving force behind OSI’s endeavors is the Company’s seasoned, multi-disciplined and dedicated team of approximately 500 research and development, regulatory, sales, marketing, commercial and business professionals. Performance has been and will continue to be the key to OSI’s success. Through its three business teams – (OSI) Oncology, (OSI) Eyetech and (OSI) Prosidion, the Company currently markets three FDA-approved drugs, including Tarceva® ( www.osip.com )
OSI Pharmaceuticals , Inc.
Suite 110 58 South Service Road
Melville, New York 11747
USA
Tel: (631) 962-2000
Fax: (631) 752-3880